COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Phase II Study of Radiation Therapy and Vismodegib for Advanced Head/Neck Basal Cell Carcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01835626
Recruitment Status : Completed
First Posted : April 19, 2013
Last Update Posted : October 29, 2019
Genentech, Inc.
Information provided by (Responsible Party):
Sue Yom, University of California, San Francisco

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : September 10, 2019
Actual Study Completion Date : September 10, 2019